Polymyalgia rheumatica – Life with Disease

Go back

Polymyalgia rheumatica is an inflammatory condition that causes sudden pain and stiffness in the shoulders, neck, and hips, typically affecting people over 50 years of age. Understanding the outlook, natural course, and daily impact of this condition can help patients and their families navigate the journey ahead with greater confidence and preparedness.

Prognosis and What to Expect

When someone receives a diagnosis of polymyalgia rheumatica, one of the first questions they often ask is about the future. The good news is that with proper treatment, most people experience significant improvement in their symptoms quite rapidly. The prognosis for polymyalgia rheumatica is generally positive, and many people are able to return to a normal lifestyle and regular activities once treatment begins to work.

The typical treatment course involves taking corticosteroid medication, which is a type of steroid medicine, for approximately 12 months to 2 years. During this time, the medication dose is gradually reduced as symptoms improve. Within just a few days of starting treatment, many people notice a dramatic relief from their pain and stiffness. Some patients even report feeling better after a single dose, though for others the response may take two to three weeks to become fully apparent.[11]

Most people with polymyalgia rheumatica will need to continue taking a low dose of the steroid medicine for about two years to prevent symptoms from returning. After this time, the condition often improves on its own and treatment can be stopped. However, there is a chance that symptoms may return after treatment ends, which is known as a relapse. When this happens, patients may need to restart or adjust their medication.[11]

It’s important to understand that polymyalgia rheumatica itself does not typically lead to life-threatening complications when properly treated. The condition is manageable, and with appropriate care, people can expect to maintain their quality of life. The main challenge lies in managing the long-term use of steroid medications and watching for any associated complications, such as the development of giant cell arteritis, a more serious related condition.[2]

Natural Progression Without Treatment

Understanding how polymyalgia rheumatica progresses when left untreated is important for appreciating the value of medical intervention. Without treatment, the condition can significantly interfere with a person’s ability to move and function in daily life. The pain and stiffness that characterize polymyalgia rheumatica do not simply go away on their own in most cases, though some evidence suggests the condition may eventually improve naturally after a year or more without treatment.[5]

When polymyalgia rheumatica is not treated, the inflammation continues unchecked. This ongoing inflammation leads to persistent muscle stiffness and pain, particularly in the shoulders, neck, and hips. The stiffness is typically worse in the morning, often lasting more than 30 to 45 minutes, and can return after periods of inactivity. This constant discomfort can become unbearable and severely limit mobility.[2]

Without medical intervention, people may find themselves increasingly unable to perform basic daily tasks. Simple activities like getting dressed, brushing hair, getting in and out of a car, or rising from a low chair become difficult or impossible. Raising the arms above the shoulders may be particularly challenging. This progressive loss of mobility can lead to a cycle of decreased activity, which in turn can worsen stiffness and lead to muscle weakness.[2]

⚠️ Important
Untreated polymyalgia rheumatica can lead to severe mobility problems that affect independence and quality of life. More concerning is the risk of developing giant cell arteritis, a serious condition that can cause vision loss or stroke if not treated promptly. Anyone experiencing new headaches, jaw pain, or vision changes should seek immediate medical attention.

Another important consideration is the potential development of giant cell arteritis, also known as temporal arteritis. Studies show that about 10% to 20% of people with polymyalgia rheumatica may develop this more serious condition, which causes inflammation of large blood vessels in the head and neck. Without treatment, this risk remains present and can lead to serious complications.[2]

Possible Complications

While polymyalgia rheumatica itself is not immediately life-threatening, several complications can arise, particularly if the condition is left untreated or if treatment is not properly managed. Understanding these potential complications helps patients and families recognize warning signs and seek timely medical care.

The most significant complication is the development of giant cell arteritis. This condition occurs in approximately 10% to 20% of people with polymyalgia rheumatica, though the relationship works both ways—about 40% to 60% of people with giant cell arteritis also have polymyalgia rheumatica. Giant cell arteritis causes inflammation of large blood vessels, particularly the arteries in the head and neck, including the aorta, which is the major artery carrying blood from the heart to the rest of the body.[2]

The symptoms of giant cell arteritis require immediate medical attention. These include new or persistent headaches that develop suddenly, pain in the jaw muscles or tongue when eating or talking, problems with vision such as double vision or loss of vision in one or both eyes, and a tender scalp. If any of these symptoms appear, patients should contact their doctor immediately or call emergency services. Unlike polymyalgia rheumatica alone, giant cell arteritis can lead to serious problems like stroke or permanent blindness if not treated quickly.[14]

Another set of complications relates to reduced mobility. When pain and stiffness become severe, people may find it increasingly difficult to move and exercise. This can lead to a downward spiral where decreased activity leads to muscle weakness, weight gain, and further loss of function. Being unable to raise the arms over the shoulders, get up from chairs, or walk comfortably can result in falls and injuries, particularly concerning for older adults who may already have age-related balance issues.[2]

Treatment with corticosteroids, while necessary and effective, carries its own set of potential complications. Long-term use of these medications can lead to increased appetite and weight gain, high blood pressure, weakening of the bones known as osteoporosis, stomach ulcers, increased risk of infections particularly with the varicella-zoster virus that causes chickenpox and shingles, and changes in mental state including depression, anxiety, mood changes, or even hallucinations. The risk of these side effects generally improves as the dose of the steroid medication is gradually reduced over time.[11]

Due to the risk of osteoporosis from steroid use, older patients may need additional medications to prevent bone fractures. Regular check-ups are essential to monitor for high blood pressure, bone loss, weight changes, cataracts, sleep disturbances, and skin changes such as bruising or thinning. These monitoring appointments help catch complications early when they are easier to manage.[6]

Impact on Daily Life

Polymyalgia rheumatica can have a profound effect on nearly every aspect of daily life, from physical activities to emotional well-being, social connections, and work responsibilities. Understanding these impacts helps patients and families prepare for and cope with the changes that may come.

Physically, the pain and stiffness characteristic of polymyalgia rheumatica most significantly affect the morning hours. Many people describe the morning stiffness as severe, lasting at least 30 to 45 minutes or longer. This morning difficulty means that basic self-care tasks become challenging. Getting out of bed can require all of a person’s strength. Dressing becomes a struggle, particularly putting on socks and shoes, buttoning shirts, or pulling shirts over the head. Activities that involve raising the arms, such as brushing hair, reaching for items on high shelves, or washing one’s back, may become impossible without assistance.[1]

The impact extends beyond personal care. Many people find that hobbies and leisure activities they once enjoyed become difficult or impossible. Gardening, which involves bending and reaching, may need to be modified or abandoned temporarily. Sports and physical recreation may be curtailed. Even simple pleasures like playing with grandchildren or preparing favorite recipes can become sources of frustration when the body doesn’t cooperate.[15]

Emotionally, living with persistent pain and loss of independence can take a toll. Depression is listed as one of the possible symptoms of polymyalgia rheumatica, and it’s not difficult to understand why. The sudden onset of severe limitations can be frightening and disheartening, especially for people who were previously active and independent. The uncertainty about how long symptoms will last and concerns about the future can create anxiety. Some people may also experience mood changes as a side effect of the steroid medications used for treatment.[3]

Socially, polymyalgia rheumatica can lead to isolation. When it becomes difficult to get out of the house, attend social gatherings, or participate in community activities, people may withdraw from their social circles. The fear of not being able to manage stairs, use public restrooms independently, or keep up with others during activities can prevent people from accepting invitations. Additionally, the fatigue that often accompanies polymyalgia rheumatica can make socializing feel exhausting rather than enjoyable.[15]

For those still working, polymyalgia rheumatica can present significant challenges. Jobs that require physical labor, lifting, or repetitive arm movements may become impossible to perform. Even office work can be difficult if it requires prolonged sitting, which can increase stiffness, or extensive computer use, which may be painful when shoulder and arm movement is limited. Some people may need to reduce their work hours, take medical leave, or even consider early retirement, which can have financial and psychological consequences.

Fortunately, there are strategies to help manage these impacts. Using assistive devices can make daily activities easier. Tools like long-handled brushes for bathing and hair care, reachers or grabbers for retrieving items, smaller and lighter cooking pots, and carts for carrying laundry can help maintain independence. Choosing clothing that doesn’t require raising arms repeatedly, such as buttoned shirts instead of pullovers, or using elastic shoelaces instead of traditional ones, can simplify dressing.[18]

Staying active is important, even though it may seem counterintuitive when experiencing pain. While strenuous movements should be avoided, gentle exercise can actually help reduce stiffness. Swimming, walking, gardening in moderation, and gentle stretching exercises like yoga or tai chi can keep muscles and joints flexible. Starting slowly and gradually increasing activity as symptoms improve is key. It’s also important to rotate activities so that the same muscles and joints aren’t overused.[15]

Managing stress through relaxation techniques such as meditation, deep breathing exercises, or engaging in calming activities like reading, listening to music, or watching favorite shows can help both physically and emotionally. Sharing feelings with friends, family, or a counselor can provide much-needed emotional support. Getting adequate sleep—at least seven to nine hours per night—allows the body to rest and heal.[18]

⚠️ Important
The impact of polymyalgia rheumatica on daily life varies from person to person. What works for one individual may not work for another. It’s important to work closely with healthcare providers to find the right combination of medication, lifestyle adjustments, and support that works best for your unique situation. Don’t hesitate to ask for help when needed—maintaining independence sometimes means accepting assistance strategically.

Support for Family Members

Family members play a crucial role in supporting someone with polymyalgia rheumatica, particularly when it comes to navigating clinical trials and research opportunities. Understanding what clinical trials are and how they might benefit their loved one can help families become active partners in care.

Clinical trials are research studies that test new ways to prevent, detect, or treat diseases. For polymyalgia rheumatica, clinical trials might investigate new medications, different dosing strategies for existing treatments, or alternative approaches to managing symptoms and reducing side effects. Participating in a clinical trial can give patients access to cutting-edge treatments before they become widely available, while also contributing to medical knowledge that will help future patients.[5]

Family members can help by learning about available clinical trials for polymyalgia rheumatica. Resources like ClinicalTrials.gov provide searchable databases of studies happening across the country and around the world. When reviewing trial information, families should look for details about eligibility requirements, the purpose of the study, what participation involves, potential risks and benefits, and where the trial is being conducted. This information-gathering role can be particularly valuable when the patient is dealing with pain and fatigue that make research difficult.

Once a potentially suitable clinical trial is identified, family members can assist with the practical aspects of participation. This might include helping arrange transportation to and from study visits, which may be frequent during certain phases of a trial. They can attend appointments with the patient to take notes, ask questions, and help remember the information provided by research staff. Having a second person present during medical discussions is valuable because it’s easy to forget important details, especially when dealing with the stress and discomfort of illness.

Families can also help patients prepare questions to ask before enrolling in a trial. Important questions include: What is the purpose of this study? What treatments or procedures are involved? What are the possible risks and benefits? How long will the trial last? Will there be any costs? What other treatment options are available? What happens after the trial ends? Having these questions written down and asking them together can ensure that all concerns are addressed before making a decision.

During trial participation, family support remains important. Families can help track symptoms, medication schedules, and any side effects that occur. They can remind patients about study visits and help maintain communication with the research team. If concerning symptoms develop, a family member may be the first to notice changes and can help ensure that the patient reports them promptly to the study doctors.

Beyond clinical trials, families provide invaluable day-to-day support. Understanding that morning stiffness is typically the worst time of day can help family members plan assistance accordingly. Perhaps morning responsibilities can be adjusted, or extra time can be built into the morning routine. Helping with tasks that are difficult or painful—like putting on socks, preparing meals, or carrying heavy items—can make a significant difference in the patient’s quality of life and independence.

Emotional support is equally important as physical assistance. Living with chronic pain and limitation can be discouraging, and having family members who listen without judgment, offer encouragement, and show patience during difficult times is tremendously valuable. At the same time, families should be mindful not to take over completely, as maintaining as much independence as possible is important for the patient’s self-esteem and physical health.

Families can also help advocate for their loved one in healthcare settings. This might mean ensuring that doctors are aware of all symptoms, asking about new treatment options, or requesting referrals to specialists such as rheumatologists who have particular expertise in treating polymyalgia rheumatica. They can help organize medical information, keep track of appointments, and ensure that prescribed medications are being taken correctly.

Finally, family caregivers need to remember to take care of themselves as well. Watching a loved one struggle with pain and limitation is emotionally taxing. Connecting with support groups for caregivers, maintaining their own health routines, and asking for help from other family members or friends can prevent burnout. A healthy, supported caregiver is better able to provide the sustained support that someone with polymyalgia rheumatica needs.

💊 Registered drugs used for this disease

List of officially registered medicines that are used in the treatment of this condition, based only on the provided sources:

  • Prednisolone – A corticosteroid medication that works by blocking the effects of certain chemicals that cause inflammation inside the body. It is the main treatment for polymyalgia rheumatica, typically prescribed at a moderate dose that is gradually reduced over time. Treatment usually lasts 12 months to 2 years.
  • Prednisone – A corticosteroid medication, typically prescribed at low doses of 10-15 mg per day, that can quickly relieve aching and stiffness in polymyalgia rheumatica. The dose is gradually reduced over time and may be tapered off after about a year, though some patients need it for 2 to 3 years.
  • Methotrexate – An immunosuppressant medicine used to suppress the immune system. It may be prescribed for patients with polymyalgia rheumatica who have frequent relapses or do not respond to normal steroid treatment, or when long-term steroid use is problematic due to side effects.
  • Hydroxychloroquine – A medication that may be tried in patients for whom long-term steroid use is felt to be problematic because of side effects.
  • Sarilumab – A biologic medication recently approved by the Food and Drug Administration for the treatment of polymyalgia rheumatica.

Ongoing Clinical Trials on Polymyalgia rheumatica

  • Study of baricitinib versus placebo for treating polymyalgia rheumatica in adult patients

    Recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    France
  • Study on Leflunomide for Preventing Relapses in Patients with Polymyalgia Rheumatica During Steroid Reduction

    Recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    The Netherlands
  • Diagnostic Accuracy of 68Ga‑FAPI‑46 PET/CT in Patients with Suspected Giant Cell Arteritis and Polymyalgia Rheumatica

    Not yet recruiting

    1 1
    The Netherlands
  • A study to evaluate the safety and effectiveness of resomelagon in patients with polymyalgia rheumatica who are in remission using glucocorticoids

    Not yet recruiting

    Investigated diseases:
    Investigated drugs:
    Denmark
  • Study of RSV vaccines Arexvy and Abrysvo in patients with inflammatory rheumatic diseases receiving anti-rheumatic treatments

    Not yet recruiting

    1 1 1 1
    Sweden
  • Study on Baricitinib for New-Onset Polymyalgia Rheumatica Patients to Reduce Steroid Use

    Not recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Austria Czechia Italy
  • Study on Rituximab for Reducing Steroid Use in Newly Diagnosed Polymyalgia Rheumatica Patients

    Not recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    The Netherlands
  • Study of Prednisolone and SPI-62 for Patients with Polymyalgia Rheumatica

    Not recruiting

    1 1
    Investigated diseases:
    Investigated drugs:
    Germany Poland
  • Study on Rituximab for Patients with Relapsing Polymyalgia Rheumatica to Reduce Steroid Use

    Not recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    The Netherlands

References

https://www.mayoclinic.org/diseases-conditions/polymyalgia-rheumatica/symptoms-causes/syc-20376539

https://my.clevelandclinic.org/health/diseases/25215-polymyalgia-rheumatica

https://www.nhs.uk/conditions/polymyalgia-rheumatica/

https://www.ncbi.nlm.nih.gov/books/NBK537274/

https://medlineplus.gov/polymyalgiarheumatica.html

https://rheumatology.org/patients/polymyalgia-rheumatica

https://www.arthritis.org/diseases/polymyalgia-rheumatica

https://www.mayoclinic.org/diseases-conditions/polymyalgia-rheumatica/diagnosis-treatment/drc-20376545

https://www.mayoclinic.org/diseases-conditions/polymyalgia-rheumatica/diagnosis-treatment/drc-20376545

https://my.clevelandclinic.org/health/diseases/25215-polymyalgia-rheumatica

https://www.nhs.uk/conditions/polymyalgia-rheumatica/treatment/

https://pubmed.ncbi.nlm.nih.gov/30904473/

https://www.brighamandwomens.org/medicine/rheumatology-inflammation-immunity/arthritis-and-joint-diseases-center/polymyalgia-rheumatica

https://www.nhs.uk/conditions/polymyalgia-rheumatica/

https://www.overlakearthritis.com/how-to-thrive-with-polymyalgia-rheumatica-tips-for-living-well-with-pmr/

https://www.mayoclinic.org/diseases-conditions/polymyalgia-rheumatica/diagnosis-treatment/drc-20376545

https://my.clevelandclinic.org/health/diseases/25215-polymyalgia-rheumatica

https://www.arthritis-health.com/blog/3-strategies-coping-polymyalgia-rheumatica-pmr

https://www.nhs.uk/conditions/polymyalgia-rheumatica/treatment/

https://www.youtube.com/watch?v=uJl42Zq_pxg

https://tristatearthritis.com/polymyalgia-rheumatica/4-tips-on-how-to-best-cope-with-polymyalgia-rheumatica-pmr/

FAQ

Can polymyalgia rheumatica go away on its own without treatment?

While some evidence suggests that polymyalgia rheumatica may eventually improve naturally after a year or more without treatment, leaving it untreated can cause severe mobility problems and significantly interfere with daily activities. Without treatment, the pain can be unbearable and people may find themselves unable to perform basic tasks like dressing or getting out of bed. Additionally, untreated polymyalgia rheumatica carries the risk of developing giant cell arteritis, a more serious condition. Treatment with steroid medication typically provides relief within days, making untreated waiting generally not advisable.

Why is polymyalgia rheumatica worse in the morning?

The stiffness and pain from polymyalgia rheumatica are typically much worse in the morning, often lasting more than 30 to 45 minutes after waking. This occurs because during sleep and periods of inactivity, inflammation builds up in the muscles and joints. The stiffness tends to improve with movement and activity as the day progresses. This same pattern of worsening after inactivity can happen at any time—for example, after sitting for a long car ride or remaining in one position for an extended period.

Will I need to take steroids forever for polymyalgia rheumatica?

Most people with polymyalgia rheumatica will need to take corticosteroid medication for 12 months to 2 years. Treatment typically begins with a moderate dose that is gradually reduced every 1 to 2 months as symptoms improve. After about two years, the condition often improves on its own and treatment can be stopped. However, symptoms may return after stopping treatment (a relapse), in which case medication may need to be restarted. Some patients may need to continue treatment for 2 to 3 years depending on their individual response.

What is the connection between polymyalgia rheumatica and giant cell arteritis?

Polymyalgia rheumatica and giant cell arteritis are closely related conditions that some experts consider to be part of the same spectrum of disease. About 10% to 20% of people with polymyalgia rheumatica develop giant cell arteritis, while 40% to 60% of people with giant cell arteritis also have polymyalgia rheumatica. Giant cell arteritis is more serious because it involves inflammation of large blood vessels in the head and neck and can lead to stroke or vision loss if not treated promptly. Warning signs include new headaches, jaw pain when eating or talking, and vision problems.

Can younger people get polymyalgia rheumatica?

Polymyalgia rheumatica rarely affects anyone under 50 years of age, and it’s very uncommon in people younger than 50. Most people diagnosed with the condition are over 65, with the highest rates occurring in people between ages 70 and 75. The reason why it mainly affects older adults is not entirely clear, but age is one of the strongest risk factors for developing this condition. Women are also affected more frequently than men, experiencing the condition more than twice as often.

🎯 Key takeaways

  • Polymyalgia rheumatica typically responds dramatically to steroid treatment, with many people feeling significantly better within just a few days of starting medication.
  • Morning stiffness lasting more than 45 minutes is a hallmark symptom, often making simple tasks like getting dressed or brushing hair extremely difficult.
  • About 10% to 20% of people with polymyalgia rheumatica may develop giant cell arteritis, a serious condition requiring immediate medical attention to prevent vision loss or stroke.
  • Most people need to take corticosteroid medication for 12 months to 2 years, with the dose gradually reduced as symptoms improve.
  • Staying active with gentle exercises like swimming, walking, or yoga helps prevent stiffness from worsening, even though moving may initially feel uncomfortable.
  • The condition is strongly age-related, rarely occurring in people under 50 and most common in those between 70 and 75 years old.
  • Simple modifications like using long-handled brushes, grabber tools, and elastic shoelaces can help maintain independence despite physical limitations.
  • Regular monitoring is essential during treatment to watch for steroid side effects such as osteoporosis, high blood pressure, weight gain, and increased infection risk.